Inventor · disambiguated record
Margret Schottelius
Also filed as: SCHOTTELIUS MARGRET
7 granted patents·2 pending applications·14 citations·filing 2002–2024
78Inventor score
Files withUNIV MUENCHEN TECH5ACADEMISCH ZIEKENHUIS LEIDEN1DEMMER OLIVER1MALLINCKRODT INC1WESTER HANS-JURGEN1
Top patents by PatentIndex Score
9 records- 0178US11944691B2CXCR4-targeted diagnostic and therapeutic agents with reduced species selectivityUNIV MUENCHEN TECH·Filed 2019·Granted Apr 2, 2024·1 cites·10 claims
- 0277US8575100B2Tc and Re labeled radioactive glycosylated octreotide derivativesWESTER HANS-JURGEN·Filed 2009·Granted Nov 5, 2013·3 cites·8 claims
- 0376US11639373B2Therapeutic and diagnostic agents for cancerUNIV MUENCHEN TECH·Filed 2019·Granted May 2, 2023·1 cites·28 claims
- 0474US9266924B2Cyclopentapeptide derivatives and uses thereofDEMMER OLIVER·Filed 2011·Granted Feb 23, 2016·5 cites·17 claims
- 0570US10919938B2Modified cyclopentapeptides and uses thereofUNIV MUENCHEN TECH·Filed 2014·Granted Feb 16, 2021·2 cites·11 claims
- 0667US2024293587A1Cxcr4-targeted diagnostic and therapeutic agents with reduced species selectivityUNIV MUENCHEN TECH·Filed 2024·Application pending·0 cites
- 0759US7589061B2Tc and Re labeler radioactive glycosylated octreotide derivativesMALLINCKRODT INC·Filed 2002·Granted Sep 15, 2009·2 cites·25 claims
- 0848US2025288704A1Cxcr4-ligands for diagnostic and therapeutic use and precursors thereofUNIV MUENCHEN TECH·Filed 2022·Application pending·0 cites
- 0934US12419976B2Hybrid tracers for targeted cancer imaging and treatmentACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Granted Sep 23, 2025·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Margret Schottelius files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →